[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE234085T1 - Schnell freisetzende tablette enthaltend tolfenaminsäure oder ein pharmazeutisch verträgliches salz davon - Google Patents

Schnell freisetzende tablette enthaltend tolfenaminsäure oder ein pharmazeutisch verträgliches salz davon

Info

Publication number
ATE234085T1
ATE234085T1 AT96943021T AT96943021T ATE234085T1 AT E234085 T1 ATE234085 T1 AT E234085T1 AT 96943021 T AT96943021 T AT 96943021T AT 96943021 T AT96943021 T AT 96943021T AT E234085 T1 ATE234085 T1 AT E234085T1
Authority
AT
Austria
Prior art keywords
pharmaceutically acceptable
acceptable salt
quick release
release tablet
tablet containing
Prior art date
Application number
AT96943021T
Other languages
English (en)
Inventor
Knud Erik Gebhard-Hansen
Karen Bjornsdottir
Lars Hedevang Christensen
Soren Bols Pedersen
Original Assignee
Gea Farmaceutisk Fabrik As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gea Farmaceutisk Fabrik As filed Critical Gea Farmaceutisk Fabrik As
Application granted granted Critical
Publication of ATE234085T1 publication Critical patent/ATE234085T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT96943021T 1995-12-20 1996-12-19 Schnell freisetzende tablette enthaltend tolfenaminsäure oder ein pharmazeutisch verträgliches salz davon ATE234085T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK144895 1995-12-20
PCT/DK1996/000548 WO1997022340A1 (en) 1995-12-20 1996-12-19 Rapid release tablet comprising tolfenamic acid or a pharmaceutically acceptable salt thereof

Publications (1)

Publication Number Publication Date
ATE234085T1 true ATE234085T1 (de) 2003-03-15

Family

ID=8104933

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96943021T ATE234085T1 (de) 1995-12-20 1996-12-19 Schnell freisetzende tablette enthaltend tolfenaminsäure oder ein pharmazeutisch verträgliches salz davon

Country Status (27)

Country Link
US (1) US6036975A (de)
EP (1) EP0869783B1 (de)
JP (1) JP2000515489A (de)
CN (1) CN1147295C (de)
AR (1) AR004395A1 (de)
AT (1) ATE234085T1 (de)
AU (1) AU1190097A (de)
BR (1) BR9612057A (de)
CA (1) CA2244396A1 (de)
CZ (1) CZ293422B6 (de)
DE (1) DE69626676T2 (de)
DK (1) DK0869783T3 (de)
EE (1) EE9800186A (de)
ES (1) ES2191781T3 (de)
HR (1) HRP960598A2 (de)
HU (1) HU224030B1 (de)
IL (1) IL124356A (de)
MX (1) MX9803918A (de)
NO (1) NO316869B1 (de)
NZ (1) NZ324674A (de)
PL (1) PL186915B1 (de)
RO (1) RO117589B1 (de)
RU (1) RU2166939C2 (de)
TR (1) TR199801126T2 (de)
TW (1) TW430561B (de)
WO (1) WO1997022340A1 (de)
ZA (1) ZA9610714B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9802973D0 (sv) 1998-09-03 1998-09-03 Astra Ab Immediate release tablet
US6599530B2 (en) * 1998-09-14 2003-07-29 Orion Corporation Oral compacted composition comprising catechol derivatives
KR20020062323A (ko) * 1999-12-06 2002-07-25 펜웨스트 파머슈티칼즈 컴파니 제약학적 초붕해제
CA2311734C (en) * 2000-04-12 2011-03-08 Bristol-Myers Squibb Company Flash-melt oral dosage formulation
US20050208468A1 (en) * 2003-09-15 2005-09-22 Beske Oren E Assays with primary cells
US20070259829A1 (en) * 2006-03-24 2007-11-08 Maen Abdelrahim Uses of diphenyl/diphenylamine carboxylic acids
TWI405574B (zh) * 2007-06-21 2013-08-21 Otsuka Pharma Co Ltd 藥學固體製劑及其製造方法
US8367427B2 (en) * 2008-08-20 2013-02-05 Baxter International Inc. Methods of processing compositions containing microparticles
US11389454B2 (en) * 2016-09-07 2022-07-19 Celgene Corporation Tablet compositions
CN111184707B (zh) * 2020-02-20 2021-04-27 中山大学 托芬那酸或其药学上可接受的盐在制备预防和/或治疗新型冠状病毒炎症药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE116061C (de) *
FI89004C (fi) * 1988-02-16 1993-08-10 Pertti J Neuvonen Anvaendning av tillsatsmedel foer oekning av absorptionshastigheten av laekemedel i orala laekemedelspreparat
IT1276689B1 (it) * 1995-06-09 1997-11-03 Applied Pharma Res Forma farmaceutica solida ad uso orale

Also Published As

Publication number Publication date
NO316869B1 (no) 2004-06-07
PL327584A1 (en) 1998-12-21
RO117589B1 (ro) 2002-05-30
CZ293422B6 (cs) 2004-04-14
ES2191781T3 (es) 2003-09-16
CA2244396A1 (en) 1997-06-26
CN1208345A (zh) 1999-02-17
WO1997022340A1 (en) 1997-06-26
CN1147295C (zh) 2004-04-28
US6036975A (en) 2000-03-14
PL186915B1 (pl) 2004-03-31
EP0869783B1 (de) 2003-03-12
DE69626676D1 (de) 2003-04-17
JP2000515489A (ja) 2000-11-21
EP0869783A1 (de) 1998-10-14
HRP960598A2 (en) 1998-02-28
AR004395A1 (es) 1998-11-04
IL124356A0 (en) 1998-12-06
DK0869783T3 (da) 2003-06-02
HUP9903410A2 (hu) 2000-04-28
AU1190097A (en) 1997-07-14
NZ324674A (en) 2000-01-28
MX9803918A (es) 1998-09-30
BR9612057A (pt) 1999-02-23
CZ194398A3 (cs) 1998-11-11
ZA9610714B (en) 1997-06-30
TR199801126T2 (xx) 1998-08-21
HU224030B1 (hu) 2005-05-30
NO982875L (no) 1998-08-19
TW430561B (en) 2001-04-21
HUP9903410A3 (en) 2000-05-29
RU2166939C2 (ru) 2001-05-20
DE69626676T2 (de) 2003-12-18
EE9800186A (et) 1998-12-15
IL124356A (en) 2001-05-20
NO982875D0 (no) 1998-06-19

Similar Documents

Publication Publication Date Title
NO2009004I2 (no) Mavacoxib eller et farmasøytisk akseptabelt salt derav
NO2009028I2 (no) Gefitinib eller et farmasøytisk akseptabelt salt derav
DE59608081D1 (de) Transcorneales arzneimittelfreigabesystem
FI973243A0 (fi) Uusi farmaseuttinen yhdistelmä
ITMI932519A0 (it) Compressa farmaceutica a rilascio controllato, di forma lenticolare
PE10195A1 (es) Medicamento en forma de comprimido con liberacion retardada de sustancia activa
NO2010003I2 (no) Prukaloprid eller et farmasøytisk aksepterbart syreaddisjonssalt derav
DE68900356D1 (de) Pharmazeutische zusammensetzung die ein dihydropyridinderivat enthaelt.
BR9604198A (pt) Cursor auto-travante para um zíper
DE69625189D1 (de) Tablette mit gesteuerter freisetzung
EP0567653A4 (en) Drug for hepatic diseases
DE69128569D1 (de) Tablette mit verzögerter Wirkstoffabgabe
ATE234085T1 (de) Schnell freisetzende tablette enthaltend tolfenaminsäure oder ein pharmazeutisch verträgliches salz davon
BR9607095A (pt) Composto composição farmacêutica e processos para fabricar e para administrar um composto
FI970058A (fi) Uusi suun kautta annettava farmaseuttinen valmiste, joka sisältää omepratsolin magnesiumsuolaa
DK0625355T5 (da) Tablet med forbedret biotilgængelighed indeholdende dichlormethylendiphosphonsyre som virksomt stof
DK0587047T3 (da) Farmaceutisk præparat på gestagenbasis
DE69632787D1 (de) Pharmazeutische pellets
NO965448D0 (no) Farmasöytiske forbindelser
LV11966A (lv) Pretiekaisumu lidzeklis arigai lietosanai
ES553013A0 (es) Un procedimiento para preparar sales o esteres farmaceuticamente aceptables de 3'-azido-3'-dexositimidina.
ATE68699T1 (de) Pharmazeutische zusammensetzung die ein dihydropyridinderivat enthaelt.
IT9022493A0 (it) Composizione farmaceutica a rilascio controllato contenente un sale farmaceuticamente accettabile di buflomedil
KR960030149U (ko) 탈방장치를 갖는 신발
UA1292S (uk) Таблетка фармацевтична

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0869783

Country of ref document: EP

REN Ceased due to non-payment of the annual fee